FDA recall D-0060-2023
ImprimisRx NJ · Class II · drug
Product
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
Reason for recall
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Distribution
Nationwide in the USA
Key facts
- Status
- Terminated
- Initiation date
- 2022-11-09
- Report date
- 2022-11-23
- Termination date
- 2023-08-23
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Ledgewood, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0060-2023